Global COVID-19 Nucleic Acid Testing Kits Market Research Report 2021

1 COVID-19 Nucleic Acid Testing Kits Market Overview

• 1.1 Product Overview and Scope of COVID-19 Nucleic Acid Testing Kits
• 1.2 COVID-19 Nucleic Acid Testing Kits Segment by Type
  • 1.2.1 Global COVID-19 Nucleic Acid Testing Kits Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Fluorescent PCR
  • 1.2.3 Thermostatic Amplification Chip
• 1.3 COVID-19 Nucleic Acid Testing Kits Segment by Application
  • 1.3.1 COVID-19 Nucleic Acid Testing Kits Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Scientific Research
  • 1.3.4 Diagnostic Center
• 1.4 Global COVID-19 Nucleic Acid Testing Kits Market Size Estimates and Forecasts
  • 1.4.1 Global COVID-19 Nucleic Acid Testing Kits Revenue 2016-2027
  • 1.4.2 Global COVID-19 Nucleic Acid Testing Kits Sales 2016-2027
  • 1.4.3 COVID-19 Nucleic Acid Testing Kits Market Size by Region: 2016 Versus 2021 Versus 2027

2 COVID-19 Nucleic Acid Testing Kits Market Competition by Manufacturers

• 2.1 Global COVID-19 Nucleic Acid Testing Kits Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global COVID-19 Nucleic Acid Testing Kits Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global COVID-19 Nucleic Acid Testing Kits Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers COVID-19 Nucleic Acid Testing Kits Manufacturing Sites, Area Served, Product Type
• 2.5 COVID-19 Nucleic Acid Testing Kits Market Competitive Situation and Trends
  • 2.5.1 COVID-19 Nucleic Acid Testing Kits Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest COVID-19 Nucleic Acid Testing Kits Players Market Share by Revenue
  • 2.5.3 Global COVID-19 Nucleic Acid Testing Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 COVID-19 Nucleic Acid Testing Kits Retrospective Market Scenario by Region

• 3.1 Global COVID-19 Nucleic Acid Testing Kits Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global COVID-19 Nucleic Acid Testing Kits Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America COVID-19 Nucleic Acid Testing Kits Market Facts & Figures by Country
  • 3.3.1 North America COVID-19 Nucleic Acid Testing Kits Sales by Country
  • 3.3.2 North America COVID-19 Nucleic Acid Testing Kits Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe COVID-19 Nucleic Acid Testing Kits Market Facts & Figures by Country
  • 3.4.1 Europe COVID-19 Nucleic Acid Testing Kits Sales by Country
  • 3.4.2 Europe COVID-19 Nucleic Acid Testing Kits Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific COVID-19 Nucleic Acid Testing Kits Market Facts & Figures by Region
  • 3.5.1 Asia Pacific COVID-19 Nucleic Acid Testing Kits Sales by Region
  • 3.5.2 Asia Pacific COVID-19 Nucleic Acid Testing Kits Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America COVID-19 Nucleic Acid Testing Kits Market Facts & Figures by Country
  • 3.6.1 Latin America COVID-19 Nucleic Acid Testing Kits Sales by Country
  • 3.6.2 Latin America COVID-19 Nucleic Acid Testing Kits Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa COVID-19 Nucleic Acid Testing Kits Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa COVID-19 Nucleic Acid Testing Kits Sales by Country
  • 3.7.2 Middle East and Africa COVID-19 Nucleic Acid Testing Kits Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global COVID-19 Nucleic Acid Testing Kits Historic Market Analysis by Type

• 4.1 Global COVID-19 Nucleic Acid Testing Kits Sales Market Share by Type (2016-2021)
• 4.2 Global COVID-19 Nucleic Acid Testing Kits Revenue Market Share by Type (2016-2021)
• 4.3 Global COVID-19 Nucleic Acid Testing Kits Price by Type (2016-2021)

5 Global COVID-19 Nucleic Acid Testing Kits Historic Market Analysis by Application

• 5.1 Global COVID-19 Nucleic Acid Testing Kits Sales Market Share by Application (2016-2021)
• 5.2 Global COVID-19 Nucleic Acid Testing Kits Revenue Market Share by Application (2016-2021)
• 5.3 Global COVID-19 Nucleic Acid Testing Kits Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Roche Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Seegene
  • 6.2.1 Seegene Corporation Information
  • 6.2.2 Seegene Description and Business Overview
  • 6.2.3 Seegene COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Seegene Product Portfolio
  • 6.2.5 Seegene Recent Developments/Updates
• 6.3 PharmACT
  • 6.3.1 PharmACT Corporation Information
  • 6.3.2 PharmACT Description and Business Overview
  • 6.3.3 PharmACT COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 PharmACT Product Portfolio
  • 6.3.5 PharmACT Recent Developments/Updates
• 6.4 Everlywell
  • 6.4.1 Everlywell Corporation Information
  • 6.4.2 Everlywell Description and Business Overview
  • 6.4.3 Everlywell COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Everlywell Product Portfolio
  • 6.4.5 Everlywell Recent Developments/Updates
• 6.5 Biopanda
  • 6.5.1 Biopanda Corporation Information
  • 6.5.2 Biopanda Description and Business Overview
  • 6.5.3 Biopanda COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Biopanda Product Portfolio
  • 6.5.5 Biopanda Recent Developments/Updates
• 6.6 Mylab Discovery
  • 6.6.1 Mylab Discovery Corporation Information
  • 6.6.2 Mylab Discovery Description and Business Overview
  • 6.6.3 Mylab Discovery COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Mylab Discovery Product Portfolio
  • 6.6.5 Mylab Discovery Recent Developments/Updates
• 6.7 Integrated DNA Technologies
  • 6.6.1 Integrated DNA Technologies Corporation Information
  • 6.6.2 Integrated DNA Technologies Description and Business Overview
  • 6.6.3 Integrated DNA Technologies COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Integrated DNA Technologies Product Portfolio
  • 6.7.5 Integrated DNA Technologies Recent Developments/Updates
• 6.8 Cosara Diagnostics
  • 6.8.1 Cosara Diagnostics Corporation Information
  • 6.8.2 Cosara Diagnostics Description and Business Overview
  • 6.8.3 Cosara Diagnostics COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cosara Diagnostics Product Portfolio
  • 6.8.5 Cosara Diagnostics Recent Developments/Updates
• 6.9 Solgent
  • 6.9.1 Solgent Corporation Information
  • 6.9.2 Solgent Description and Business Overview
  • 6.9.3 Solgent COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Solgent Product Portfolio
  • 6.9.5 Solgent Recent Developments/Updates
• 6.10 Kogene Biotech
  • 6.10.1 Kogene Biotech Corporation Information
  • 6.10.2 Kogene Biotech Description and Business Overview
  • 6.10.3 Kogene Biotech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Kogene Biotech Product Portfolio
  • 6.10.5 Kogene Biotech Recent Developments/Updates
• 6.11 SD Biosensor
  • 6.11.1 SD Biosensor Corporation Information
  • 6.11.2 SD Biosensor COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.11.3 SD Biosensor COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 SD Biosensor Product Portfolio
  • 6.11.5 SD Biosensor Recent Developments/Updates
• 6.12 Biosewoom
  • 6.12.1 Biosewoom Corporation Information
  • 6.12.2 Biosewoom COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.12.3 Biosewoom COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Biosewoom Product Portfolio
  • 6.12.5 Biosewoom Recent Developments/Updates
• 6.13 Curative
  • 6.13.1 Curative Corporation Information
  • 6.13.2 Curative COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.13.3 Curative COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Curative Product Portfolio
  • 6.13.5 Curative Recent Developments/Updates
• 6.14 Biolidics
  • 6.14.1 Biolidics Corporation Information
  • 6.14.2 Biolidics COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.14.3 Biolidics COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Biolidics Product Portfolio
  • 6.14.5 Biolidics Recent Developments/Updates
• 6.15 Shanghai ZJ Bio-Tech
  • 6.15.1 Shanghai ZJ Bio-Tech Corporation Information
  • 6.15.2 Shanghai ZJ Bio-Tech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.15.3 Shanghai ZJ Bio-Tech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Shanghai ZJ Bio-Tech Product Portfolio
  • 6.15.5 Shanghai ZJ Bio-Tech Recent Developments/Updates
• 6.16 Shanghai Geneodx Biotech
  • 6.16.1 Shanghai Geneodx Biotech Corporation Information
  • 6.16.2 Shanghai Geneodx Biotech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.16.3 Shanghai Geneodx Biotech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Shanghai Geneodx Biotech Product Portfolio
  • 6.16.5 Shanghai Geneodx Biotech Recent Developments/Updates
• 6.17 INNOVITA
  • 6.17.1 INNOVITA Corporation Information
  • 6.17.2 INNOVITA COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.17.3 INNOVITA COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 INNOVITA Product Portfolio
  • 6.17.5 INNOVITA Recent Developments/Updates
• 6.18 Genomics Biotech (Wuhan)
  • 6.18.1 Genomics Biotech (Wuhan) Corporation Information
  • 6.18.2 Genomics Biotech (Wuhan) COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.18.3 Genomics Biotech (Wuhan) COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Genomics Biotech (Wuhan) Product Portfolio
  • 6.18.5 Genomics Biotech (Wuhan) Recent Developments/Updates
• 6.19 Zhongshan Daan Gene
  • 6.19.1 Zhongshan Daan Gene Corporation Information
  • 6.19.2 Zhongshan Daan Gene COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.19.3 Zhongshan Daan Gene COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Zhongshan Daan Gene Product Portfolio
  • 6.19.5 Zhongshan Daan Gene Recent Developments/Updates
• 6.20 Sanaure
  • 6.20.1 Sanaure Corporation Information
  • 6.20.2 Sanaure COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.20.3 Sanaure COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Sanaure Product Portfolio
  • 6.20.5 Sanaure Recent Developments/Updates
• 6.21 Shanghai Bio-Germ
  • 6.21.1 Shanghai Bio-Germ Corporation Information
  • 6.21.2 Shanghai Bio-Germ COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.21.3 Shanghai Bio-Germ COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 Shanghai Bio-Germ Product Portfolio
  • 6.21.5 Shanghai Bio-Germ Recent Developments/Updates
• 6.22 Guangzhou Wonfo Bio-Tech
  • 6.22.1 Guangzhou Wonfo Bio-Tech Corporation Information
  • 6.22.2 Guangzhou Wonfo Bio-Tech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.22.3 Guangzhou Wonfo Bio-Tech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Guangzhou Wonfo Bio-Tech Product Portfolio
  • 6.22.5 Guangzhou Wonfo Bio-Tech Recent Developments/Updates
• 6.23 Chengdu Boaojing Bio-Tech
  • 6.23.1 Chengdu Boaojing Bio-Tech Corporation Information
  • 6.23.2 Chengdu Boaojing Bio-Tech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.23.3 Chengdu Boaojing Bio-Tech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Chengdu Boaojing Bio-Tech Product Portfolio
  • 6.23.5 Chengdu Boaojing Bio-Tech Recent Developments/Updates
• 6.24 Beijing XABT
  • 6.24.1 Beijing XABT Corporation Information
  • 6.24.2 Beijing XABT COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.24.3 Beijing XABT COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.24.4 Beijing XABT Product Portfolio
  • 6.24.5 Beijing XABT Recent Developments/Updates
• 6.25 Bioscience(Chongqing) Bio-Tech
  • 6.25.1 Bioscience(Chongqing) Bio-Tech Corporation Information
  • 6.25.2 Bioscience(Chongqing) Bio-Tech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.25.3 Bioscience(Chongqing) Bio-Tech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.25.4 Bioscience(Chongqing) Bio-Tech Product Portfolio
  • 6.25.5 Bioscience(Chongqing) Bio-Tech Recent Developments/Updates
• 6.26 Maccura Bio-Tech
  • 6.26.1 Maccura Bio-Tech Corporation Information
  • 6.26.2 Maccura Bio-Tech COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.26.3 Maccura Bio-Tech COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.26.4 Maccura Bio-Tech Product Portfolio
  • 6.26.5 Maccura Bio-Tech Recent Developments/Updates
• 6.27 Xiamen InnoDx
  • 6.27.1 Xiamen InnoDx Corporation Information
  • 6.27.2 Xiamen InnoDx COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.27.3 Xiamen InnoDx COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.27.4 Xiamen InnoDx Product Portfolio
  • 6.27.5 Xiamen InnoDx Recent Developments/Updates
• 6.28 Guangdong Hecin-Scientific
  • 6.28.1 Guangdong Hecin-Scientific Corporation Information
  • 6.28.2 Guangdong Hecin-Scientific COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.28.3 Guangdong Hecin-Scientific COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.28.4 Guangdong Hecin-Scientific Product Portfolio
  • 6.28.5 Guangdong Hecin-Scientific Recent Developments/Updates
• 6.29 Wuhan Easydiagnosis Biomedicine
  • 6.29.1 Wuhan Easydiagnosis Biomedicine Corporation Information
  • 6.29.2 Wuhan Easydiagnosis Biomedicine COVID-19 Nucleic Acid Testing Kits Description and Business Overview
  • 6.29.3 Wuhan Easydiagnosis Biomedicine COVID-19 Nucleic Acid Testing Kits Sales, Revenue and Gross Margin (2016-2021)
  • 6.29.4 Wuhan Easydiagnosis Biomedicine Product Portfolio
  • 6.29.5 Wuhan Easydiagnosis Biomedicine Recent Developments/Updates

7 COVID-19 Nucleic Acid Testing Kits Manufacturing Cost Analysis

• 7.1 COVID-19 Nucleic Acid Testing Kits Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of COVID-19 Nucleic Acid Testing Kits
• 7.4 COVID-19 Nucleic Acid Testing Kits Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 COVID-19 Nucleic Acid Testing Kits Distributors List
• 8.3 COVID-19 Nucleic Acid Testing Kits Customers

9 COVID-19 Nucleic Acid Testing Kits Market Dynamics

• 9.1 COVID-19 Nucleic Acid Testing Kits Industry Trends
• 9.2 COVID-19 Nucleic Acid Testing Kits Growth Drivers
• 9.3 COVID-19 Nucleic Acid Testing Kits Market Challenges
• 9.4 COVID-19 Nucleic Acid Testing Kits Market Restraints

10 Global Market Forecast

• 10.1 COVID-19 Nucleic Acid Testing Kits Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of COVID-19 Nucleic Acid Testing Kits by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of COVID-19 Nucleic Acid Testing Kits by Type (2022-2027)
• 10.2 COVID-19 Nucleic Acid Testing Kits Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of COVID-19 Nucleic Acid Testing Kits by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of COVID-19 Nucleic Acid Testing Kits by Application (2022-2027)
• 10.3 COVID-19 Nucleic Acid Testing Kits Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of COVID-19 Nucleic Acid Testing Kits by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of COVID-19 Nucleic Acid Testing Kits by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List